In­vestors add $17M to Em­u­late Se­ries B as Co­v­ance part­ners; UMass pro­fes­sor to work with Spark on next-gen vec­tors

Em­u­late has topped up its B round with a fresh in­jec­tion of $17 mil­lion, bring­ing the to­tal to $45 mil­lion. The biotech has been …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.